69.56 USD
-0.41 (-0.59%)
Last: Feb 9, 2026, 10:42 AM
We assign a fundamental rating of 7 out of 10 to DXCM. DXCM was compared to 186 industry peers in the Health Care Equipment & Supplies industry. DXCM scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DXCM is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make DXCM a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year DXCM was profitable.
- In the past year DXCM had a positive cash flow from operations.
- Each year in the past 5 years DXCM has been profitable.
- DXCM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 9.61%, DXCM belongs to the best of the industry, outperforming 93.01% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 26.44%, DXCM belongs to the top of the industry, outperforming 97.31% of the companies in the same industry.
- DXCM's Return On Invested Capital of 15.72% is amongst the best of the industry. DXCM outperforms 95.70% of its industry peers.
- DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.80%.
- The last Return On Invested Capital (15.72%) for DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
- The Profit Margin of DXCM (15.96%) is better than 93.01% of its industry peers.
- DXCM's Profit Margin has improved in the last couple of years.
- DXCM has a Operating Margin of 18.41%. This is amongst the best in the industry. DXCM outperforms 90.32% of its industry peers.
- DXCM's Operating Margin has improved in the last couple of years.
- The Gross Margin of DXCM (60.20%) is better than 61.29% of its industry peers.
- DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DXCM is creating some value.
- DXCM has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for DXCM has been increased compared to 5 years ago.
- The debt/assets ratio for DXCM has been reduced compared to a year ago.
2.2 Solvency
- DXCM has an Altman-Z score of 5.10. This indicates that DXCM is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.10, DXCM is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
- DXCM has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as DXCM would need 2.36 years to pay back of all of its debts.
- The Debt to FCF ratio of DXCM (2.36) is better than 86.02% of its industry peers.
- DXCM has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.47, DXCM is in line with its industry, outperforming 44.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.1 |
ROIC/WACC1.68
WACC9.36%
2.3 Liquidity
- A Current Ratio of 1.56 indicates that DXCM should not have too much problems paying its short term obligations.
- The Current ratio of DXCM (1.56) is worse than 70.97% of its industry peers.
- A Quick Ratio of 1.38 indicates that DXCM should not have too much problems paying its short term obligations.
- DXCM has a Quick ratio (1.38) which is comparable to the rest of the industry.
- DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 9.41% over the past year.
- DXCM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.25% yearly.
- DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
- DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
- Based on estimates for the next years, DXCM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.05% on average per year.
- Based on estimates for the next years, DXCM will show a quite strong growth in Revenue. The Revenue will grow by 13.28% on average per year.
EPS Next Y27.5%
EPS Next 2Y23.7%
EPS Next 3Y22.67%
EPS Next 5Y22.05%
Revenue Next Year15.45%
Revenue Next 2Y14.12%
Revenue Next 3Y13.7%
Revenue Next 5Y13.28%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 37.40, DXCM can be considered very expensive at the moment.
- DXCM's Price/Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 71.51% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.93, DXCM is valued a bit more expensive.
- The Price/Forward Earnings ratio is 27.55, which means the current valuation is very expensive for DXCM.
- Based on the Price/Forward Earnings ratio, DXCM is valued a bit cheaper than the industry average as 72.58% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of DXCM to the average of the S&P500 Index (27.77), we can say DXCM is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.4 | ||
| Fwd PE | 27.55 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, DXCM is valued a bit cheaper than 73.12% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of DXCM indicates a rather cheap valuation: DXCM is cheaper than 83.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.55 | ||
| EV/EBITDA | 23.23 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of DXCM may justify a higher PE ratio.
- A more expensive valuation may be justified as DXCM's earnings are expected to grow with 22.67% in the coming years.
PEG (NY)1.36
PEG (5Y)1.28
EPS Next 2Y23.7%
EPS Next 3Y22.67%
5. Dividend
5.1 Amount
- DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:DXCM (2/9/2026, 10:42:48 AM)
69.56
-0.41 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-12 2026-02-12/amc
Inst Owners99.77%
Inst Owner Change-4.37%
Ins Owners0.19%
Ins Owner Change2.62%
Market Cap27.13B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85.95
Price Target87.74 (26.14%)
Short Float %3.98%
Short Ratio2.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)-0.9%
PT rev (3m)-14.09%
EPS NQ rev (1m)0.41%
EPS NQ rev (3m)0.29%
EPS NY rev (1m)0.16%
EPS NY rev (3m)-0.07%
Revenue NQ rev (1m)0.39%
Revenue NQ rev (3m)0.24%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.4 | ||
| Fwd PE | 27.55 | ||
| P/S | 6.01 | ||
| P/FCF | 25.55 | ||
| P/OCF | 18.73 | ||
| P/B | 9.95 | ||
| P/tB | 10.34 | ||
| EV/EBITDA | 23.23 |
EPS(TTM)1.86
EY2.67%
EPS(NY)2.52
Fwd EY3.63%
FCF(TTM)2.72
FCFY3.91%
OCF(TTM)3.71
OCFY5.34%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.36
PEG (5Y)1.28
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 5.1 |
F-Score5
WACC9.36%
ROIC/WACC1.68
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.5%
EPS Next 2Y23.7%
EPS Next 3Y22.67%
EPS Next 5Y22.05%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.45%
Revenue Next 2Y14.12%
Revenue Next 3Y13.7%
Revenue Next 5Y13.28%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.37%
EBIT Next 5Y30.77%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 37.4 and the Price/Book (PB) ratio is 9.95.